路瑾 - AI Profile | 人才画像

基本信息

浏览量：99

职业迁徙

个人简介

擅长原发性巨球蛋白血症，原发系统性淀粉样变性，多发性骨髓瘤，淋巴瘤等恶性血液病的诊治，细胞免疫治疗

研究兴趣

论文共 324 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Burden of Multiple Myeloma in China: Trends from 1990 to 2021 and Forecasts for 2050

Xuelin Dou, Guixiang Duan, Yanting Zhong,Yang Liu,Nan Peng, Lei Wen, Jinlei Qi,Maigeng Zhou,Xiaohui Zhang,Jin Lu

Cancer Letterspp.217440, (2025)

引用0浏览0引用

Weekly Selinexor, Bortizomib and Dexamethasone (svd) Versus Twice Weekly Bortizomib and Dexamethasone (vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench Study

Jin Lu, Liangquan Geng,Lijuan Chen,Peng Liu,Yuping Zhong,Zhuogang Liu, Zhongjun Xia,Jianqing Mi,Chunrui Li,Xi Zhang,Yanjuan He, Yongqiang Wei,

Bloodno. Supplement 1 (2024): 4748-4748

引用0浏览0引用

Subcutaneous Daratumumab (DARA) + Bortezomib, Cyclophosphamide, and Dexamethasone (vcd) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival and Final Major Organ Deterioration Progression-Free Survival Results from the Phase 3 Andromeda Study

Efstathios Kastritis,Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, Hans C. Lee, Vaishali Sanchorawala, Peter Mollee,Jin Lu,Stefan Schönland, Moshe E Gatt,Kenshi Suzuki,

Bloodno. Supplement 1 (2024): 891-891

引用0浏览0引用

Safety and Efficacy of Baricitinib in Steroid-Resistant or Relapsed Immune Thrombocytopenia: an Open-Label Pilot Study

Peng Zhao,Zhuo-Yu An,Hai-Xia Fu,Hui-Xin Liu,Cheng-Jie Feng,Qiu-Sha Huang,Jin Wu,Ye-Jun Wu,Li-Ping Yang,Qing-Yuan Qu,Yu-Xiu Chen,Meng-Lin Li,

AMERICAN JOURNAL OF HEMATOLOGYno. 10 (2024): 1951-1958

引用0浏览0WOS引用

The Establishment of a Multiple Myeloma Clinical Registry in the Asia–Pacific Region: the Asia–Pacific Myeloma and Related Diseases Registry (APAC MRDR)

Naomi Aoki,Pin-Yen Chen,Wenming Chen,Wee Joo Chng, Gin,Yeow Tee Goh,Jian Hou,Jeffrey Huang,Kihyun Kim,Je Jung Lee,Jin Lu,Zoe K. McQuilten,

BMC MEDICAL RESEARCH METHODOLOGYno. 1 (2024)

引用0浏览0WOS引用

Bortezomib, pomalidomide, and dexamethasone is a potential effective regimen for patients with relapse and refractory AL amyloidosis and monoclonal immunoglobulin deposition disease PA147 (#162)

Yang Liu,JIN LU

crossref（2024）

引用0浏览0引用

Using Machine Learning Approaches to Develop a Fast and Easy-to-perform Diagnostic Tool for Patients with Light Chain Amyloidosis: a Retrospective Real-World Study

Yang Liu,Xuelin Dou,Xiaojing Yan,Shiyu Ma, Chong Ye, Xiaohong Wang,Jin Lu

Annals of Hematologypp.1-18, (2024)

引用0浏览0WOS引用

Global Burden of Disease of Multiple Myeloma in China from 1990 to 2021

Guixiang Duan, Xuelin Dou, Yanting Zhong, Kai-Yan Liu, Jinlei Qi,Jin Lu, Maigeng Zhou

Bloodno. Supplement 1 (2024): 6974-6974

引用0浏览0引用

A Matched Comparison of Pola-R-CHP Vs. R-CHOP for DLBCL with Extranodal Involvement

Shenmiao Yang,Rong Wei,Yang Liu, Xuelin Dou, Lei Wen,Jin Lu,Fengrong Wang,Xiaodong Mo,Xiaojun Huang

Bloodno. Supplement 1 (2024): 6478-6478

引用0浏览0引用

Obinutuzumab-induced Acute Thrombocytopenia: a Case Report and Literature Review

Xuelin Dou, Kongyang Li,Jin Lu

Frontiers in oncology (2024): 1509567-1509567

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Jin Lu(路瑾)

其他

论文共 324 篇作者统计合作学者相似作者